The release of histones from dying cells is associated with microvascular thrombosis. Since histones activate platelets, this could represent a possible pathogenic mechanism. In this study we assessed the influence of histones on the procoagulant potential of human platelets in platelet-rich plasma (PRP) and in purified systems. Histones dose-dependently enhanced thrombin generation in PRP in the absence of any trigger as evaluated by calibrated automated thrombinography whether or not the contact phase was inhibited.
Introduction
Histones are cationic proteins which associate with DNA in nucleosomes and are involved in chromatin remodeling and gene transcription regulation. Despite their physiological nuclear localization, nucleosomes have been found in the circulation of both healthy subjects and patients, where they can be released from dying cells 1 or actively secreted by activated inflammatory cells (neutrophils, basophils and mast cells) in the form of "extracellular traps", i.e. complex structures of DNA strands, histones and cell specific granule proteins. 2, 3 High blood levels of nucleosomes have been detected in several inflammatory, ischemic, autoimmune and neoplastic diseases 4 ; in some cases a correlation with disease severity has been found. 5 Whether extracellular nucleosomes are merely bystanders or active mediators in disease and which role the histones play are important emerging questions. Histones are known to possess cytotoxic properties against both microorganisms 6 and eukaryotic cells 7 . Xu et al 8 reported that extracellular histones behave as late mediators of cell damage and organ dysfunction during the hyperinflammatory reaction that characterizes sepsis, as proved by the efficacy of a neutralizing antibody against histone H4 in reducing mortality in several experimental models of murine sepsis.
Moreover, direct injection of histones into mice resulted in death with pathological lesions suggestive of a massive prothrombotic response similar to that found in sepsis, including diffuse microvascular thrombosis, fibrin and platelet deposition in the lung alveoli and intra-alveolar hemorrhage. Fuchs et al 9 recently reported that neutrophil extracellular traps (NETs) perfused with blood or platelet-rich plasma (PRP) stimulate platelets to adhere and aggregate and promote thrombus formation; NET integrity was considered essential, as treatment with DNase and heparin (which avidly binds histones) abrogated their effect;
histones H4 and H3 were found responsible for directly inducing aggregation of human washed platelets.
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In addition to their known role in hemostasis and thrombosis, platelets are widely recognized as mediators of inflammation and immune responses. 10, 11 They have been shown to express the toll-like receptors (TLRs), a major class of pattern-recognition receptors involved in the innate immune response through the recognition of microbial structures conserved among species (pathogen-associated molecular patterns, PAMPs) and of endogenous molecules released from damaged cells (damage-associated molecular patterns, DAMPs). 12 TLR1, 2, 4, 6, 8 and 9 have been found on human platelets 13,14 and shown to be functional. For example, the TLR2 agonist PAM 3 -CSK4 induces platelet adhesion, degranulation, aggregation and the formation of platelet-neutrophil aggregates; 15 lipopolysaccharide (LPS), a TLR4 agonist, induces platelet P-selectin expression, ATP secretion and primes platelets to aggregate in response to low dose thrombin. 16 Platelet
TLRs might thus represent a bridge between inflammation and coagulation, as supported by studies demonstrating that TLRs are responsible for LPS-induced thrombocytopenia. 17, 18 In our laboratory, J. Xu recently found that histones specifically induce TLR2 and TLR4 mediated reporter gene expression in a cell line over-expressing different classes of TLRs (J. Xu, et al., manuscript submitted April 2011).
Given the increasing interest around histones as new damage mediators and the importance of platelets in thrombosis and inflammation, we investigated the platelet-activating properties of histones, focusing mainly on the procoagulant potential of platelets in the plasma environment and in purified systems, and the potential involvement of platelet TLRs in this process. We show that histones induce a procoagulant phenotype in human platelets, thereby accelerating blood coagulation and enhancing thrombin generation, and that TLR2 and TLR4 are involved in the platelet response to histones. 
Materials and methods

Materials
The following reagents were purchased: calf thymus histones, PGE 1 and 20% POPS were prepared by extrusion using a 100-nm Nucleopore membrane as reported. 19 mAb HFV-237 against human factor V/Va was prepared as previously described. 20 Polyphosphate, 70 units average length (polyP) was a kind gift from Dr.
Thomas Staffel, BK Giulini GmbH. mAb S12 recognizing P-selectin was kindly provided by centrifuging PRP at 1,000g for 15 minutes at RT followed by a second centrifugation of the supernatant at 12,000g for 10 minutes. Isolated platelets were prepared by gel-filtration as described. 21 Briefly, PRP prepared from blood drawn into acid-citrate-dextrose was applied to a Sepharose CL-2B column and platelets were eluted with Tyrode's buffer, pH 7.5. Gel-filtered platelets (GFP) were counted and normalized to a concentration of 2 x 10 5 µL -1 in Tyrode's buffer.
Thrombin generation in PRP
Plasma thrombin generation was analyzed by the calibrated automated thrombinography (CAT) method as described by Hemker et al. 22 In brief, 80 µL PRP was dispensed into round-bottom 96-well plates (Immulon 2HB, Dynex Technologies) and incubated for 10 minutes at 37°C with the indicated concentrations of histones. Analysis was performed in a final volume of 120 µL and started upon addition of 20 µL of a mixture containing 100 Thrombin generation was started after 3 minutes by adding 2 nmol L -1 FXa. As factor Va was not added, it was provided entirely by platelets. The reaction was stopped after 1.5 minutes with ice cold buffer (HBS with 0.5% BSA) containing 10 mmol L -1 EDTA and the amount of thrombin formed determined by the rate of hydrolysis of the chromogenic 
Statistical evaluation
All data are represented as means ± SD. Statistical analyses were performed using the Student's paired t-test with a two-tailed distribution. P values <0.05 were considered statistically significant.
Results
Histones promote thrombin generation in PRP through platelet activation
We determined the effect of a natural mixture of histones on thrombin generation in human PRP as evaluated by CAT. No trigger was added to recalcified plasma in order to increase the sensitivity of the test to the procoagulant potential of platelets. Histones (0-160 µg mL -1 ) were incubated with PRP, then calcium was added along with the fluorogenic thrombin substrate. In citrated PRP, histones dose-dependently stimulated thrombin generation ( Figure 1A ). In particular, they shortened both the lag time and the time-to-peak and increased the maximal thrombin generated; ETP was only slightly enhanced by the presence of histones. Under the experimental conditions employed and in the absence of any platelet agonist the clotting cascade could be initiated by the activation of the contact system. 23 To avoid the interference of spontaneously activated FXII on the clotting process, recalcification experiments were performed in PRP anticoagulated with citrate plus CTI, an inhibitor of FXIIa. 23 The use of CTI in our assay prevents FXII activated during plasma preparation from influencing thrombin generation but, at the same time, allows the intrinsic
For personal use only. on . by guest www.bloodjournal.org From pathway to function when platelets are present, since CTI is much less effective in inhibiting FXIIa generated by activated platelets than that formed in solution. 24 In CTIinhibited PRP no thrombin was detected in the control sample during the course of the experiment, whereas a clear dose-dependent enhancement of thrombin generation was still induced by histones ( Figure 1B) , with an obvious shortening of the lag time and time-topeak (about 4-fold reduction between the highest and the lowest concentrations), a striking increase of the peak (7-fold augmentation), and a more modest rise of the ETP (1.5-fold increase) ( Figure 1C ). Similar results were obtained in whole blood based on measurement of prothrombin fragment 1+2 (F.S. and C.T.A., data not shown). To assess the relative role of the different histones present in the preparation used, experiments were performed using individual recombinant histones. As shown in Figure 1D , the capacity to induce thrombin generation in CTI-inhibited PRP could be attributed mainly to histones H3 and, especially, H4.
To verify the dependence of the histone effect on platelets, thrombin generation was evaluated in CTI-inhibited plasma in which platelets were omitted or substituted with POPS-containing liposomes. Histones did not induce detectable thrombin generation (F.S. and C.T.A., data not shown), indicating that they were not able to directly drive the clotting cascade and, thus, they induced thrombin generation in PRP by activating platelets. 
Thrombin generation in histone-treated PRP is driven by platelet-derived polyP
Activated platelets are thought to trigger the clotting cascade by expressing functional tissue factor (TF) 25 or by secreting polyP. 26 Activation of coagulation in histone-treated CTI-inhibited PRP did not appear to be due to TF expression, because inclusion of a neutralizing anti-TF mAb in the assay failed to significantly modify the thrombin generation pattern produced by 40 μ g mL -1 histones (no antibody vs anti-TF mAb: lag time,
31.4 ± 6.5 vs 36 ± 5.6 minutes, not significant; time-to-peak, 45.9 ± 7.7 vs 50 ± 6.6, n.s.; 
which simulated platelet activation, and thrombin generation was then measured by CAT.
While no thrombin was formed in the control and histone-treated samples, only traces were produced by polyP, confirming the efficacy of CTI; when histones were present along with polyP thrombin was formed after a long latency and then increased at a high rate, reaching considerable peak values ( Figure 3B ). Histones appeared thus to strongly enhance the procoagulant activity of polyP in CTI-inhibited PPP, and the same effect was observed in the presence of the anti-FXII antibody ( Figure 3C ) and in a FXII-deficient PPP (F.S. and C.T.A., data not shown). These data argue for activation of the clotting cascade at a different level and suggest that platelet-derived polyP may initiate the coagulation pathway in a FXII-independent manner when histones are present.
Histones induce platelet activation and expression of procoagulant activity in GFP
To exclude an effect of histones on plasma proteins which could lead to the expression of a procoagulant phenotype by platelets activated by histones, we investigated the effect of by histones, producing 70% P-selectin positive platelets ( Figure 4C ).
APC and heparin abolish the platelet activating potential of histones
APC and heparin are of great importance in the therapy of hyper-inflammatory and thrombotic conditions and possess known anti-histone properties. APC can cleave histones in vitro and in vivo, thus producing fragments which lose their ability to damage endothelial cells, 8 and heparin is able to bind histones tighter than DNA. 28 We tested the possibility that treatment of histones with these molecules could affect their ability to activate platelets. Histones preincubated with APC for 30 minutes at 37°C failed to induce platelet aggregation (F.S. and C.T.A., data not shown) or the surface expression of Pselectin, PS or FV, and even a short preincubation of histones with heparin similarly resulted in the complete loss of their platelet activating potential ( Figure 5 ). These results emphasize the effectiveness of APC and heparin in antagonizing histones as platelet activators and indicate that platelet activation was not attributable to contaminants present in the histone preparation.
TLR2 and TLR4 are involved in platelet activation induced by histones
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The involvement of TLR2 and TLR4 in the histone-induced platelet responses was investigated by means of neutralizing antibodies. GFP were treated for 20 minutes at RT with monoclonal antibodies directed against TLR2 or TLR4 or control IgG prior to incubation with 40 μ g mL -1 histones and the expression of PS, FV and P-selectin was evaluated by flow cytometry. Both TLR2 and TLR4 antibodies reduced the exposure of PS (from 10% to 3%), P-selectin (from 70% to 40%) and FV (from 40% to 20%) roughly to the same extent, whereas isotype control antibody did not differ from the histones alone 
Histone-DNA complexes augment thrombin generation in PRP
Histones can be released by dying cells as free histones or in complex with DNA (nucleosomes). We hypothesized that DNA in complex with histones might modify the 
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ability of histones to increase thrombin generation. We therefore evaluated thrombin generation in CTI-inhibited PRP incubated with histone-DNA complexes in the absence of any trigger and compared it to the complex formed between histones and de-N-heparin, a modified heparin devoid of anticoagulant activity. 29 As shown in Figure 7 , unlike de-Nheparin, which antagonized histones, the presence of DNA enhanced the histone-dependent thrombin generation.
Discussion
A pathogenic relationship between extracellular histones and thrombosis has been recently proposed based on the observation that injection of histones in mice induces thrombotic lesions reminiscent of those found in severe sepsis. 8 Another recent report 9 demonstrated that NETs induced platelet adhesion and aggregation and fibrin deposition occurred on their surface, suggesting that these structures can promote thrombus formation. The histone component of NETs was deemed of primary importance because recombinant H3 and H4
were found to induce aggregation of washed platelets. However, whether and how histoneplatelet interaction affects blood coagulation remains unclear. In the present study we provide new evidence that histones can directly promote coagulation and thrombin formation through platelet-dependent mechanisms. The effects of histones were first evaluated by CAT in PRP. In recalcified citrated PRP, where coagulation is thought to be triggered by contact system activation, 23 histones induced a dose-dependent enhancement of thrombin generation, as evinced mainly from the changes in the kinetic parameters of the thrombogram (shortening of the lag time and time-to-peak and increased thrombin peak).
This suggests earlier platelet activation with consequent impact on the coagulation dynamics. In CTI-inhibited PRP where contact system activation is almost abolished, histones still induced thrombin generation in a concentration-dependent manner, whereas
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histones failed to induce detectable thrombin formation in CTI-inhibited PPP even in the presence of an exogenous procoagulant surface, indicating that they are not able to trigger thrombin generation by themselves; 2) histone-induced thrombin generation in CTIinhibited PRP was strongly reduced by several agents that interfere with platelet function at different levels, implying that the histone effect requires cellular signaling. These findings raise the question of how histone-activated platelets can trigger blood coagulation in CTIinhibited PRP.
Activated platelets have long been known to amplify the clotting reactions and recent evidence indicates that they can also trigger the clotting cascade by different pathways. TF expression in platelets is still a matter of debate. 25, 32 Under our experimental conditions neither a TF-inhibiting antibody nor the absence of FVII reduced the histone-induced enhancement of thrombin generation in PRP, thus ruling out an involvement of endogenous TF. Secretion of the inorganic polymer polyP by activated platelets is an emerging mechanism of clotting activation that sheds new light on the pathophysiological importance of the contact system. 27 Severe deficiency in FXII does not cause hemorrhage 33 but protects from thrombosis, which implies a role in pathological rather than in physiological hemostasis. 34 PolyP, along with RNA, 35 36 and the effect of histones was not appreciably modified by blocking FXII or the absence of FXII, we hypothesize that other mechanisms of clotting activation might be operative when polyP and histones are simultaneously present. The experiments performed in CTI-inhibited PPP and FXII-deficient PPP showed that the requirement for FXII by purified polyP was bypassed in the presence of histones, which may be able to modulate polyP properties. Studies are ongoing to clarify these aspects.
Experiments performed with isolated platelets showed that histones induce a wide spectrum of platelet responses. They induced aggregation of platelets in a concentration-dependent manner in agreement with recently published data. 9 At variance with the latter study performed with recombinant histones, the mixture of histones we used was from a natural source and most probably had undergone post-translational modifications, which did not impair the pro-aggregating properties. More relevant in the context of our study, is the observation that platelets, upon stimulation with histones, acquired a procoagulant phenotype as evidenced by increased surface expression of FV/Va and exposure of PS at levels that efficiently promoted thrombin formation in an assay employing purified FXa and prothrombin. Histones also up-regulated the expression of platelet P-selectin, an adhesion molecule involved in platelet adhesion to the endothelium, platelet-leukocyte aggregation, induction of TF expression by monocytes and uptake of TF-bearing microparticles, all implicated in thrombus formation. 37 Recombinant APC, the only drug approved by the US Food and Drug Administration for the treatment of sepsis, and heparin, a widely used anticoagulant agent, almost completely inhibited the whole spectrum of platelet responses to histones, thus extending previous findings on the anti-histone properties of these compounds.
We also evaluated the possible involvement of TLRs in histone-induced platelet activation.
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